Əsas səhifə

Çap

Əks əlaqə

İnfo
Prophylactic antibiotics for preventing central venous catheter infections in oncology patients

Mündəricat

Prophylactic antibiotics for preventing central venous catheter infections in oncology patients

Sübutlu məlumatların xülasələri
13.07.2017 • Sonuncu dəyişiklik 13.07.2017
Editors

Flushing the central venous catheter with a combination of vancomycin and heparin appears to reduce the rate of Gram-positive catheter-related infections in oncology patients.

A Cochrane review included 11 studies with a total of 828 subjects. Five trials compared the use of antibiotics (vancomycin, teicoplanin or ceftazidime) given before the insertion of the long-term CVC with no antibiotics, and six trials compared antibiotics (vancomycin, amikacin or taurolidine) and heparin with a heparin-only solution for flushing or locking the long-term CVC after use. Administering an antibiotic prior to insertion of the CVC did not significantly reduce Gram positive catheter-related sepsis (CRS) (five trials, 360 adults; risk ratio (RR) 0.72, 95% confidence interval (CI) 0.33 to 1.58; I² = 5 2%; P = 0.41). Flushing and locking long-term CVCs with a combined antibiotic and heparin solution significantly reduced the risk of Gram positive catheter-related sepsis compared with a heparin-only solution (468 participants, mostly children; RR 0.47, 95% CI 0.28 to 0.80; I² = 0%; P = 0.005). For a baseline infection rate of 15%, this reduction translated into a number needed to treat (NNT) of 12 (95% CI 9 to 33) to prevent one catheter-related infection. We considered this evidence to be of a moderate quality.

Comment: The quality of evidence is downgraded by imprecise results (limited study size for each comparison).

Ədəbiyyat

  1. van de Wetering MD, van Woensel JB, Lawrie TA. Prophylactic antibiotics for preventing Gram positive infections associated with long-term central venous catheters in oncology patients. Cochrane Database Syst Rev 2013;(11):CD003295.